Evidence map›Paper›PMID 30879021›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2019

Selective D

Daniel F Manvich, Alyssa K Petko, Rachel C Branco, Stephanie L Foster, Kirsten A Porter-Stransky, Kristen A Stout, Amy H Newman, Gary W Miller, Carlos A Paladini, David Weinshenker

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Substance Addiction Rehabilitation Drugs.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Effects of the selective dopamine DBehavioural brain research · 2021
    Article
  13. Article
  14. Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments.International journal of molecular sciences · 2021
    Review
  15. RGS14 Regulation of Post-Synaptic Signaling and Spine Plasticity in Brain.International journal of molecular sciences · 2021
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Daniel F ManvichDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Alyssa K PetkoDepartment of Biology, University of Texas at San Antonio Neuroscience Institute, University of Texas at San Antonio, San Antonio, TX, 78249, USA.
Rachel C BrancoDepartment of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA.ORCID http://orcid.org/0000-0001-9655-4849
Stephanie L FosterDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Kirsten A Porter-StranskyDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Kristen A StoutDepartment of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA.
Amy H NewmanMedicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, MD, 21224, USA.ORCID http://orcid.org/0000-0002-4812-9474
Gary W MillerDepartment of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA.
Carlos A PaladiniDepartment of Biology, University of Texas at San Antonio Neuroscience Institute, University of Texas at San Antonio, San Antonio, TX, 78249, USA.
David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA. dweinsh@emory.edu.
Emory University · USThe University of Texas at San Antonio · USNational Institutes of Health · USNorthwestern University · USUniversity of Notre Dame · USWestern Michigan University · US

Funding

Novel Dopamine D3 Receptor Ligands ZIADA000424 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 2009 to 2025
$25.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Graduate and Postdoctoral Training in ToxicologyT32ES012870 · NIEHS · EMORY UNIVERSITY · PI Carmen Joseph Marsit · 2004 to 2026
$9.1M
Vesicular Modulation of Dopamine Neuron ToxicityR01ES023839 · NIEHS · EMORY UNIVERSITY · PI MILLER, GARY W · 2015 to 2025
$5.0M
Cellular mechanisms of dopamine neuron burstingR01MH107229 · NIMH · UNIVERSITY OF TEXAS SAN ANTONIO · PI HSIEH, JENNY · 2016 to 2020
$1.8M
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition 5R01DA038453-02 Diversity SupplementR01DA038453 · NIDA · EMORY UNIVERSITY · PI PALADINI, CARLOS ANTONIO, WEINSHENKER, DAVID · 2015 to 2019
$1.8M
Cellular Mechanisms of Dopamine Neuron BurstingR01MH079276 · NIMH · UNIVERSITY OF TEXAS SAN ANTONIO · PI PALADINI, CARLOS ANTONIO · 2007 to 2011
$1.2M
Functional Neuroanatomy Underlying Psychosocial Stress-Induced Cocaine SeekingR00DA039991 · NIDA · ROWAN UNIVERSITY SCHOOL/OSTEOPATHIC MED · PI MANVICH, DANIEL F. · 2018 to 2020
$747k
Neurobiology of Reward ChoiceR21DA040788 · NIDA · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2016 to 2017
$414k
In Vivo whole-cell recordings of dopamine neurons in awake behaving miceR21MH113341 · NIMH · UNIVERSITY OF TEXAS SAN ANTONIO · PI PALADINI, CARLOS ANTONIO · 2017 to 2018
$383k
Functional neuroanatomy underlying psychosocial stress-induced cocaine seekingK99DA039991 · NIDA · EMORY UNIVERSITY · PI MANVICH, DANIEL F. · 2016 to 2017
$235k
Estradiol reduces mitochondrial oxidant stress in SNc DA neuronsF32AG058396 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI STOUT, KRISTEN · 2017 to 2019
$178k
NIA NIH HHS F32 AG058396NIDA NIH HHS F31 DA037652NIDA NIH HHS F31 DA044726NIDA NIH HHS K99 DA039991NIDA NIH HHS R00 DA039991NIDA NIH HHS R01 DA038453NIDA NIH HHS R21 DA040788NIDA NIH HHS ZIA DA000424NIEHS NIH HHS R01 ES023839NIEHS NIH HHS T32 ES012870NIGMS NIH HHS T32 GM008169NIMH NIH HHS R01 MH079276NIMH NIH HHS R01 MH107229NIMH NIH HHS R21 MH113341NINDS NIH HHS F32 NS098615
6 · The paper itself

Abstract

The dopamine D

Indexed as

Action PotentialsAnimalsBenzamidesCentral Nervous System SensitizationCocaineDopamineDopamine AntagonistsDose-Response Relationship, DrugDrug InteractionsIndolesMiceMotor ActivityNeuronsNucleus AccumbensPiperidinesPyridines3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indoleBenzamidesCocaineDopamineDopamine AntagonistsIndolesN-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)but-2-enyl)-4-pyridine-2-ylbenzamidePiperidinesPyridinesReceptors, Dopamine D2Receptors, Dopamine D3

Identifiers

PMID30879021
PMCPMC6785094
OpenAlexW2953004734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.